These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 400732

  • 21. Glucose tolerance after portacaval shunt in liver cirrhosis.
    Pezzarossa A, Contini S, Bonora E, Marni A, Colotto G, Capocasale E, Butturini U.
    Diabete Metab; 1986 Aug; 12(4):197-202. PubMed ID: 3533668
    [Abstract] [Full Text] [Related]

  • 22. Human plasma C-peptide immunoreactivity: its correlation with immunoreactive insulin in diabetes, and chronic liver and renal diseases.
    Kajinuma H, Kanazawa Y, Sando H, Hayashi M, Kawazu S, Kosaka K.
    Endocrinol Jpn; 1979 Feb; 26(1):65-73. PubMed ID: 436802
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Oral and intravenous glucose-induced insulin secretion in hyperthyroid patients.
    Ikeda T, Fujiyama K, Hoshino T, Takeuchi T, Mashiba H, Tominaga M.
    Metabolism; 1990 Jun; 39(6):633-7. PubMed ID: 2191191
    [Abstract] [Full Text] [Related]

  • 25. The investigation of glucose metabolism and insulin secretion in subjects of chronic hepatitis B with cirrhosis.
    Guo CH, Sun TT, Weng XD, Zhang JC, Chen JX, Deng GJ.
    Int J Clin Exp Pathol; 2015 Jun; 8(10):13381-6. PubMed ID: 26722544
    [Abstract] [Full Text] [Related]

  • 26. Serum free C-peptide response to oral glucose loading as a parameter for the monitoring of pancreatic B-cell function in diabetic patients.
    Hsieh SD, Kanazawa Y, Akanuma Y.
    Diabetes Res Clin Pract; 1985 Aug; 1(2):109-14. PubMed ID: 3915258
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion?
    Johnson DG, Alberti KG, Faber OK, Binder C.
    Lancet; 1977 Jan 01; 1(8001):10-3. PubMed ID: 63654
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Clinical and experimental studies on elevated plasma level of insulin in cirrhotic patients with portal hypertension and portosystemic collateral circulation].
    Arakawa T.
    Nihon Geka Gakkai Zasshi; 1984 May 01; 85(5):468-81. PubMed ID: 6379413
    [Abstract] [Full Text] [Related]

  • 31. [Behavior of C-peptide and immunoreactive insulin in essential obesity].
    Gragnoli G, Signorini AM, Tanganelli I, Martinelli G.
    Boll Soc Ital Biol Sper; 1979 Mar 30; 55(6):564-70. PubMed ID: 399187
    [Abstract] [Full Text] [Related]

  • 32. Effects of spontaneous portal-systemic shunting on insulin metabolism.
    Smith-Laing G, Sherlock S, Faber OK.
    Gastroenterology; 1979 Apr 30; 76(4):685-90. PubMed ID: 421995
    [Abstract] [Full Text] [Related]

  • 33. [Morphometric study on islet of Langerhans in relation to glucose tolerance in chronic obstructive pancreatitis due to pancreatoduodenal cancer].
    Kaji H, Inoue K, Miyashita T, Uchida K, Takahashi K, Tobe T.
    Nihon Geka Gakkai Zasshi; 1992 Feb 30; 93(2):169-76. PubMed ID: 1552889
    [Abstract] [Full Text] [Related]

  • 34. Changes in immunoreactive insulin, C-peptide immunoreactivity, and immunoreactive glucagon in acute viral hepatitis.
    Kaneko K, Arai M, Funatomi H, Hatta Y, Mitamura K.
    J Gastroenterol; 1995 Oct 30; 30(5):624-31. PubMed ID: 8574335
    [Abstract] [Full Text] [Related]

  • 35. Glucose and insulin metabolism in patients with hyperthyroidism due to Graves' disease.
    Mano T, Kawakubo A, Yamamoto M.
    Nagoya J Med Sci; 1994 Mar 30; 57(1-4):61-8. PubMed ID: 7898563
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Plasma insulin, C-peptide, and blood glucose in portal, hepatic and peripheral veins in liver cirrhosis. Effect of intravenous tolbutamide.
    Pelkonen R, Kallio H, Suoranta H, Karonen SL.
    Acta Endocrinol (Copenh); 1981 Aug 30; 97(4):496-502. PubMed ID: 7023164
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.